Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players

Glioblastoma is a devastating disease that despite all the information gathered so far, its optimal management remains elusive due to the absence of validated targets from clinical studies. A better clarification of the molecular mechanisms is needed. In this study, having access to IDH1 wild-type g...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Franceschi, Sara, Lessi, Francesca, Aretini, Paolo, Ortenzi, Valerio, Scatena, Cristian, Menicagli, Michele, La Ferla, Marco, Civita, Prospero, Zavaglia, Katia, Scopelliti, Claudia, Apollo, Alessandro, Carbone, Francesco Giovanni, Vannozzi, Riccardo, Bevilacqua, Generoso, Pasqualetti, Francesco, Naccarato, Antonio Giuseppe, Mazzanti, Chiara Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2018
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5963624/
https://ncbi.nlm.nih.gov/pubmed/29844869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25265
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak